T1	p 86 118	atrial fibrillation patients : a
T2	p 501 608	ACTIVE W study patients , cases with stroke and cases with bleeding were separately matched with controls .
T3	p 715 788	32 cases with ischemic stroke and 234 cases with bleeding in the analysis
T4	p 794 801	matched
T5	p 805 823	a 4:1 ratio to 122
T6	p 828 831	865
T7	p 1504 1512	patients
T8	i 28 39	INR control
T9	i 598 608	controls .
T10	i 617 632	anticoagulation
T11	o 6 13	Quality
T12	o 17 39	individual INR control
T13	o 48 82	risk of stroke and bleeding events
T14	o 223 259	international normalized ratio ( INR
T15	o 617 640	anticoagulation quality
T16	o 729 744	ischemic stroke
T17	o 764 772	bleeding
T18	o 868 876	duration
T19	o 901 907	stroke
T20	o 941 958	bleeding analysis
T21	o 1013 1024	mean TTR of
T22	o 1030 1036	stroke
T23	o 1090 1098	bleeding
T24	o 1162 1223	Time below range for stroke and time above range for bleeding
T25	o 1359 1367	bleeding
T26	o 1374 1401	spent more time below range
T27	o 1518 1536	stroke or bleeding
T28	o 1719 1740	stroke and bleeding .